Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Application of the Hartford Hospital Nomogram for Plazomicin Dosing Interval Selection in Patients with Complicated Urinary Tract Infection.

Asempa TE, Kuti JL, Seroogy JD, Komirenko AS, Nicolau DP.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00148-19. doi: 10.1128/AAC.00148-19. Print 2019 Oct.

PMID:
31358580
2.

A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant Enterobacterales.

Asempa TE, Kuti JL, Seroogy JD, Komirenko AS, Nicolau DP.

Clin Ther. 2019 Aug;41(8):1453-1462. doi: 10.1016/j.clinthera.2019.04.038. Epub 2019 Jun 24.

PMID:
31248681
3.

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies.

Trang M, Seroogy JD, Van Wart SA, Bhavnani SM, Kim A, Gibbons JA, Ambrose PG, Rubino CM.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02329-18. doi: 10.1128/AAC.02329-18. Print 2019 Apr.

4.

A Phase 1 Study To Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function.

Komirenko AS, Riddle V, Gibbons JA, Van Wart S, Seroogy JD.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01128-18. doi: 10.1128/AAC.01128-18. Print 2018 Dec.

5.

Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: an in vitro study.

Patel JH, Churchwell MD, Seroogy JD, Barriere SL, Grio M, Mueller B.

Int J Artif Organs. 2009 Oct;32(10):745-51.

PMID:
19943236

Supplemental Content

Loading ...
Support Center